Ultrasound Guided Botulinum Toxin Type A Injection of Subacromial-Subdeltoid Bursa in Hemiplegic Shoulder Pain
Status:
Recruiting
Trial end date:
2020-12-15
Target enrollment:
Participant gender:
Summary
Good shoulder function is a prerequisite for effective hand function, as well as for
performing multiple tasks involving mobility, ambulation, and activities of daily living
(ADL). A common sequela of stroke is hemiplegic shoulder pain, which can hamper functional
recovery and subsequently lead to disability. Hemiplegic shoulder pain can begin as early as
2 weeks post stroke but typically occurs within 2-3 months post stroke.
Phase:
Early Phase 1
Details
Lead Sponsor:
Benha University
Treatments:
abobotulinumtoxinA Botulinum Toxins Botulinum Toxins, Type A Methylprednisolone Acetate